Etiology, Clinical Picture, Complications and Outcomes of Necrotizing Pancreatitis in Children.
Study of the Etiology, Clinical Picture, Complications and Outcomes of Necrotizing Pancreatitis in Children.
1 other identifier
observational
102
1 country
1
Brief Summary
The aim of this research is to study the etiology, the clinical picture, the management, the complications and the outcomes of necrotic pancreatitis in children. Currently, there is a significant number of errors in the early diagnosis of AP in children associated with the complexity of differential diagnosis, which leads to the untimely verification of the correct diagnosis and, consequently, to incorrect treatment tactics, which could be accompanied by an increase in the severe forms of the disease and an increase in mortality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 20, 2024
CompletedFirst Posted
Study publicly available on registry
November 21, 2024
CompletedStudy Start
First participant enrolled
December 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 18, 2025
CompletedFebruary 20, 2025
February 1, 2025
1 month
November 20, 2024
February 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the frequency of occurrence of various etiologic causes of necrotizing pancreatitis in children
based on the study, the most common causes of necrotizing pancreatitis in children will be identified
From enrollment to the end of treatment (2 month)
Secondary Outcomes (11)
The duration from the onset of the disease to the start of the treatment
from the onset of the disease to the end of treatment (up to 20 weeks)
The duration of hospital stay
from admission to hospital until the end of treatment (up to 8 weeks)
The length of ICU stay
During ICU stay (up to 60 days)
The effect of comorbidities on the severity of the disease
from admission to hospital until the end of treatment (up to 8 weeks)
Intestinal failure
from admission to hospital until the end of treatment (up to 8 weeks)
- +6 more secondary outcomes
Study Arms (1)
Children with necrotizing pancreatitis
children who have suffered acute pacreatitis
Interventions
Only data from the patient file.
Eligibility Criteria
Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky
You may qualify if:
- Consent of the patient or legal representative
- Age from 0-18 years
- Moderate severe (MSAP) or severe acute pancreatitis (SAP) according to Atlanta criteria revisited in 2012
- Acute Pancreatitis was established in the presence of at least two of three criteria according to the classification developed by the INSPPIRE group (International Study Group of Pediatric Pancreatitis: In Search for a Cure): abdominal pain corresponding to the diagnostic hypothesis; an increase in amylase and / or lipase in the blood serum by ≥3 times; imaging findings characteristic of AP: abdominal ultrasound and/or contrast-enhanced CT.
You may not qualify if:
- mild acute pancreatitis
- chronic pancreatitis
- no consent from patient or legal representative
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky
Moscow, Moscow Oblast, 129110, Russia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Dmitriy A Pyhteev, PhD
Head of the Department of Pediatric Surgery
- PRINCIPAL INVESTIGATOR
Leonid M Elin
Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 20, 2024
First Posted
November 21, 2024
Study Start
December 1, 2024
Primary Completion
January 10, 2025
Study Completion
February 18, 2025
Last Updated
February 20, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will share
A complete dataset can be provided upon reasoned request